September 15, 2011

The use of over-the-counter medicines as a cost savings tool is catching on, of all places, at the Centers for Medicare and Medicaid.

September 12, 2011


As the clock winds down on the patent exclusivity of the industry’s biggest blockbuster drug in November, speculation continues to grow that Pfizer will look to flip the switch on an OTC version of Lipitor (atorvastatin) before generic competition whittles away at the $7 billion behemoth.